Continuation of platelet inhibiting drugs in eyelid surgery.A randomized, double-masked, placebo-controlled clinical trial. - Platelet inhibiting drugs in eyelid surgery

Phase 1

• Conditions: Patients, using platelet inhibiting drugs, due for eyelid surgery

• Registration Number: EUCTR2009-009986-32-NL
• Lead Sponsor: Rotterdam Eye Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-01-30
• Study Completion: 2011-01-20
• Last Update Posted: 19 April 2022

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 7

Inclusion Criteria

· daily use of acetylsalicylic acid or carbasalate calcium
· scheduled for surgical correction of ectropion or entropion, or for non-cosmetic upperlid blepharoplasty without fat excision

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

· concomitant use of other anticoagulant drugs (coumarin derivatives, clopidogrel, dipyridamol, Non-Steroidal Anti-Inflammatory Drugs)
· known systemic disease that affects haemostasis
· prescribing physician advising against discontinuation
· obvious fat prolapses that need to be excised in case of blepharoplasty.
· general anaesthesia

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified